NYSE:CGC - Canopy Growth Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $47.56 +1.44 (+3.12 %) (As of 02/17/2019 01:27 PM ET)Previous Close$47.56Today's Range$46.51 - $49.8652-Week Range$18.93 - $59.25Volume20.61 million shsAverage Volume12.64 million shsMarket Capitalization$11.04 billionP/E Ratio-148.63Dividend YieldN/ABeta4.46 ProfileDiscussionAnalyst RatingsChartEarningsInstitutional OwnershipHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada. Receive CGC News and Ratings via Email Sign-up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Medicinals & botanicals Sub-IndustryCannabis SectorMedical Current SymbolNYSE:CGC Previous Symbol CUSIPN/A Webwww.canopygrowth.com Phone855-558-9333Debt Debt-to-Equity RatioN/A Current Ratio0.64 Quick Ratio0.49Price-To-Earnings Trailing P/E Ratio-148.63 Forward P/E Ratio-42.09 P/E GrowthN/A Sales & Book Value Annual Sales$60.79 million Price / Sales181.64 Cash FlowN/A Price / Cash FlowN/A Book Value$4.87 per share Price / Book9.77Profitability EPS (Most Recent Fiscal Year)($0.32) Net Income$-54,880,000.00 Net Margins-503.14% Return on Equity-26.32% Return on Assets-18.43%Miscellaneous Employees1,033 Outstanding Shares232,162,000Market Cap$11.04 billion OptionableOptionable Canopy Growth (NYSE:CGC) Frequently Asked Questions What is Canopy Growth's stock symbol? Canopy Growth trades on the New York Stock Exchange (NYSE) under the ticker symbol "CGC." When is Canopy Growth's next earnings date? Canopy Growth is scheduled to release their next quarterly earnings announcement on Wednesday, June 26th 2019. View Earnings Estimates for Canopy Growth. What price target have analysts set for CGC? 5 brokers have issued 1 year price objectives for Canopy Growth's stock. Their forecasts range from $60.00 to $61.00. On average, they expect Canopy Growth's stock price to reach $60.50 in the next twelve months. This suggests a possible upside of 27.2% from the stock's current price. View Analyst Price Targets for Canopy Growth. What is the consensus analysts' recommendation for Canopy Growth? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Canopy Growth. Has Canopy Growth been receiving favorable news coverage? Media coverage about CGC stock has been trending negative on Sunday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Canopy Growth earned a coverage optimism score of -2.8 on InfoTrie's scale. They also gave headlines about the marijuana producer a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. Are investors shorting Canopy Growth? Canopy Growth saw a decrease in short interest in the month of January. As of January 31st, there was short interest totalling 21,997,984 shares, a decrease of 20.1% from the January 15th total of 27,527,254 shares. Based on an average trading volume of 12,007,458 shares, the short-interest ratio is presently 1.8 days. View Canopy Growth's Current Options Chain. Who are some of Canopy Growth's key competitors? Some companies that are related to Canopy Growth include Actelion (ALIOF), Tilray (TLRY), Aurora Cannabis (ACB), STADA Arzneimittel (STDAF), Cronos Group (CRON), USANA Health Sciences (USNA), Chromadex (CDXC), Foamix Pharmaceuticals (FOMX), Canopy Rivers (RIV), Mediwound (MDWD), Natural Alternatives International (NAII), Pharmacyte Biotech (PMCB), China Jo-Jo Drugstores (CJJD), Mannatech (MTEX) and GLG Life Tech (GLGLF). Who are Canopy Growth's key executives? Canopy Growth's management team includes the folowing people: Mr. Bruce A. Linton, Co-Founder, Chairman & Co-CEO (Age 52)Mr. Mark Anthony Nicholas Zekulin, Pres & Co-CEOMr. Timothy Rob Saunders, Exec. VP & CFOMr. Rade Kovacevic, Exec. VP of Recreational Cannabis & MD of CanadaMs. Ann Gordon, VP of Corp. Fin. Who are Canopy Growth's major shareholders? Canopy Growth's stock is owned by a variety of of institutional and retail investors. Top institutional investors include ETF Managers Group LLC (0.64%), Connor Clark & Lunn Investment Management Ltd. (0.63%), Macquarie Group Ltd. (0.57%), TD Asset Management Inc. (0.34%), Bank of Nova Scotia (0.17%) and QCI Asset Management Inc. NY (0.16%). Which institutional investors are selling Canopy Growth stock? CGC stock was sold by a variety of institutional investors in the last quarter, including Two Sigma Investments LP, D. E. Shaw & Co. Inc., Connor Clark & Lunn Investment Management Ltd., Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, Bank of America Corp DE, Essex Investment Management Co. LLC, Two Sigma Advisers LP and Macquarie Group Ltd.. Which institutional investors are buying Canopy Growth stock? CGC stock was bought by a variety of institutional investors in the last quarter, including ETF Managers Group LLC, Bank of New York Mellon Corp, Bank of Nova Scotia, Legal & General Group Plc, Intact Investment Management Inc., Mackenzie Financial Corp, Aviva PLC and Toronto Dominion Bank. How do I buy shares of Canopy Growth? Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Canopy Growth's stock price today? One share of CGC stock can currently be purchased for approximately $47.56. How big of a company is Canopy Growth? Canopy Growth has a market capitalization of $11.04 billion and generates $60.79 million in revenue each year. The marijuana producer earns $-54,880,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis. Canopy Growth employs 1,033 workers across the globe. What is Canopy Growth's official website? The official website for Canopy Growth is http://www.canopygrowth.com. How can I contact Canopy Growth? Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The marijuana producer can be reached via phone at 855-558-9333 or via email at [email protected] MarketBeat Community Rating for Canopy Growth (NYSE CGC)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 244 (Vote Outperform)Underperform Votes: 217 (Vote Underperform)Total Votes: 461MarketBeat's community ratings are surveys of what our community members think about Canopy Growth and other stocks. Vote "Outperform" if you believe CGC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/17/2019 by MarketBeat.com StaffFeatured Article: What is Considered a Good Return on Equity (ROE)?